Multiple liver and lymph node metastases.

RT and capecitabine June-August 2008

Regional radiology CT August 11, 2008

Recurrence

Gemcitabine x3 September 5, 2008-October 24, 2008

Regional radiology CT October 24, 2008

Recurrence

FOLFOX and hyperthermia January-July 2009

Regional radiology CT October 10, 2009

Recurrence

Stage at admission to BC: IVB, recurrent

BC. December 1, 2009 PB, sorafenib, riluzole, sirolimus, erlotinib to May 15, 2010. PB, sirolimus, riluzole, lapatinib to May 28, 2010

Regional radiology CT January 25, 2010

PD

775

204

Normal (blood)

4

Regional medical center October 5, 2009

APO

Regional medical center CT September 17, 2009

Mass in pancreatic tail. Multiple liver metastases

Gemcitabine and erlotinib October 20, 2009-December 29, 2009

Regional radiology CT January 26, 2010

Recurrence

Stage at admission to BC: IVB, recurrent

BC. January 25, 2010 PB, sorafenib, BVZ, capecitabine

Regional radiology CT April 16, 2010

PD

234

122

VEGF- elevated (blood)

5

Cancer institute May 6, 2008

APMD

Cancer institute CT May 2, 2008

Mass in the pancreatic head and body

Stent placement March 2008. Whipple procedure May 6, 2008

Cancer institute March 12, 2010

APO

Lung and lymph node metastases.

Gemcitabine and oxaliplatin x6 June 12, 2008- September 2, 2008

Gemcitabine and RT 99Gy September 15, 2008-October 28, 2008

Cancer institute CT November 9, 2009

Recurrence

Stage at admission to BC: IVB, recurrent

BC. April 15, 2010 PB, sorafenib, BVZ, trastuzumab, lapatinib

Regional radiology CT July 26, 2010

PD

1027

318

VEGF and HER-2- elevated (blood)

6

Cancer institute February 15, 2010

APO

Cancer institute CT May 2, 2009

Mass in the pancreatic head, body and tail

Stent placement May 2, 2009. Gemcitabine and TH302 (clinical trial) March 8, 2010-February 28, 2011

Regional radiology CT February 21, 2011

Recurrence